Other Issues:		[Index by Author]
Contents:	Volume 27, Issue 21 July 20, 2009

	EDITORIALS
	ORIGINAL REPORTS
	Breast Cancer
	Genitourinary Cancer
	Gastrointestinal Cancer
	LEUKEMIA AND BONE MARROW TRANSPLANTATION
	AIDS-RELATED CANCER
	MELANOMA
	NEUROONCOLOGY
	LYMPHOMA AND MYELOMA
	PEDIATRIC ONCOLOGY
	THORACIC ONCOLOGY
	GYNECOLOGIC CANCER
	PHASE I AND CLINICAL PHARMACOLOGY
	ERRATA
	DIAGNOSIS IN ONCOLOGY
	CORRESPONDENCE

Find articles in this issue containing these words: [Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

                                      EDITORIALS

"Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen Amy M. Fowler, Richard J. Santen, and D. Craig Allred JCO Jul 2009: 3413–3415. First published on Jun 1 2009; 10.1200/JCO.2009.21.8776. [Full Text] [PDF]

Topoisomerase II Amplification and Anthracycline-Based Chemotherapy: The Jury Is Still Out Francisco J. Esteva and Gabriel N. Hortobagyi JCO Jul 2009: 3416–3417. First published on May 26 2009; 10.1200/JCO.2009.22.6449. [Full Text] [PDF]

Chronic Inflammation and Breast Cancer Recurrence Steven W. Cole JCO Jul 2009: 3418–3419. First published on May 26 2009; 10.1200/JCO.2009.21.9782. [Full Text] [PDF]

"Staging the Aging" When Considering Androgen Deprivation Therapy for Older Men With Prostate Cancer William Dale JCO Jul 2009: 3420–3422. First published on Jun 8 2009; 10.1200/JCO.2009.22.9104. [Full Text] [PDF]

                                      ORIGINAL REPORTS
Breast Cancer

Expression of ER-36, a Novel Variant of Estrogen Receptor , and Resistance to Tamoxifen Treatment in Breast Cancer Liang Shi, Bin Dong, Zhongwu Li, Yunwei Lu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Zhaoyi Wang, and Yuntao Xie JCO Jul 2009: 3423–3429. First published on Jun 1 2009; 10.1200/JCO.2008.17.2254. [Abstract] [Full Text] [PDF]

Topoisomerase II Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013 Lyndsay N. Harris, Gloria Broadwater, Maysa Abu-Khalaf, David Cowan, Ann D. Thor, Daniel Budman, Constance T. Cirrincione, Donald A. Berry, Eric P. Winer, Clifford A. Hudis, Daniel F. Hayes, Paula Friedman, Matthew Ellis, and Lynn Dressler JCO Jul 2009: 3430–3436. First published on May 26 2009; 10.1200/JCO.2008.18.4085. [Abstract] [Full Text] [PDF]

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients Brandon L. Pierce, Rachel Ballard-Barbash, Leslie Bernstein, Richard N. Baumgartner, Marian L. Neuhouser, Mark H. Wener, Kathy B. Baumgartner, Frank D. Gilliland, Bess E. Sorensen, Anne McTiernan, and Cornelia M. Ulrich JCO Jul 2009: 3437–3444. First published on May 26 2009; 10.1200/JCO.2008.18.9068. [Abstract] [Full Text] [PDF]

Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer Gretchen Kimmick, Roger Anderson, Fabian Camacho, Monali Bhosle, Wenke Hwang, and Rajesh Balkrishnan JCO Jul 2009: 3445–3451. First published on May 18 2009; 10.1200/JCO.2008.19.2419. [Abstract] [Full Text] [PDF]

Genitourinary Cancer

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes Shabbir M.H. Alibhai, Minh Duong-Hua, Rinku Sutradhar, Neil E. Fleshner, Padraig Warde, Angela M. Cheung, and Lawrence F. Paszat JCO Jul 2009: 3452–3458. First published on Jun 8 2009; 10.1200/JCO.2008.20.0923. [Abstract] [Full Text] [PDF]

Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3? Jennifer R. Stark, Sven Perner, Meir J. Stampfer, Jennifer A. Sinnott, Stephen Finn, Anna S. Eisenstein, Jing Ma, Michelangelo Fiorentino, Tobias Kurth, Massimo Loda, Edward L. Giovannucci, Mark A. Rubin, and Lorelei A. Mucci JCO Jul 2009: 3459–3464. First published on May 11 2009; 10.1200/JCO.2008.20.4669. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma Nancy E. Kemeny, Fidel D. Huitzil Melendez, Marinela Capanu, Philip B. Paty, Yuman Fong, Lawrence H. Schwartz, William R. Jarnagin, Dina Patel, and Michael D'Angelica JCO Jul 2009: 3465–3471. First published on May 26 2009; 10.1200/JCO.2008.20.1301. [Abstract] [Full Text] [PDF]

                                      LEUKEMIA AND BONE MARROW TRANSPLANTATION

Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial Jane F. Apperley, Jorge E. Cortes, Dong-Wook Kim, Lydia Roy, Gail J. Roboz, Gianantonio Rosti, Eduardo O. Bullorsky, Elisabetta Abruzzese, Andreas Hochhaus, Dominik Heim, Carmino A. de Souza, Richard A. Larson, Jeffrey H. Lipton, H. Jean Khoury, Hyeoung-Joon Kim, Christian Sillaber, Timothy P. Hughes, Philipp Erben, Jan Van Tornout, and Richard M. Stone JCO Jul 2009: 3472–3479. First published on Jun 1 2009; 10.1200/JCO.2007.14.3339. [Abstract] [Full Text] [PDF]

                                      AIDS-RELATED CANCER

Dose-Modified Oral Chemotherapy in the Treatment of AIDS-Related Non-Hodgkin's Lymphoma in East Africa Walter O. Mwanda, Jackson Orem, Pingfu Fu, Cecilia Banura, Joweria Kakembo, Caren Auma Onyango, Anne Ness, Sherrie Reynolds, John L. Johnson, Vivek Subbiah, Jacob Bako, Henry Wabinga, Fatuma K. Abdallah, Howard J. Meyerson, Christopher C. Whalen, Michael M. Lederman, Jodi Black, Leona W. Ayers, Edward Katongole-Mbidde, and Scot C. Remick JCO Jul 2009: 3480–3488. First published on May 26 2009; 10.1200/JCO.2008.18.7641. [Abstract] [Full Text] [PDF]

                                      MELANOMA

Improved Survival for Stage IV Melanoma From an Unknown Primary Site Chris C. Lee, Mark B. Faries, Leslie A. Wanek, and Donald L. Morton JCO Jul 2009: 3489–3495. First published on May 18 2009; 10.1200/JCO.2008.18.9845. [Abstract] [Full Text] [PDF]

Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Jens Ulrich, Rudolf Stadler, Matthias Volkenandt, Stephan Grabbe, Ulrike Proske, Dirk Schadendorf, Norbert Brockmeyer, Thomas Vogt, Rainer Rompel, Roland Kaufmann, Martin Kaatz, Helmut Näher, Peter Mohr, Thomas Eigentler, Elisabeth Livingstone, and Claus Garbe JCO Jul 2009: 3496–3502. First published on May 11 2009; 10.1200/JCO.2008.21.3892. [Abstract] [Full Text] [PDF]

                                      NEUROONCOLOGY

Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience Lilyana Angelov, Nancy D. Doolittle, Dale F. Kraemer, Tali Siegal, Gene H. Barnett, David M. Peereboom, Glen Stevens, John McGregor, Kristoph Jahnke, Cynthia A. Lacy, Nancy A. Hedrick, Edna Shalom, Sandra Ference, Susan Bell, Lisa Sorenson, Rose Marie Tyson, Marianne Haluska, and Edward A. Neuwelt JCO Jul 2009: 3503–3509. First published on May 18 2009; 10.1200/JCO.2008.19.3789. [Abstract] [Full Text] [PDF]

                                      LYMPHOMA AND MYELOMA

Phase II Study of Thalidomide Plus Dexamethasone Induction Followed by Tandem Melphalan-Based Autotransplantation and Thalidomide-Plus-Prednisone Maintenance for Untreated Multiple Myeloma: A Southwest Oncology Group Trial (S0204) Mohamad A. Hussein, Vanessa Bolejack, Jeffrey A. Zonder, Brian G.M. Durie, Andrzej J. Jakubowiak, John J. Crowley, and Bart Barlogie JCO Jul 2009: 3510–3517. First published on Jun 22 2009; 10.1200/JCO.2008.19.9240. [Abstract] [Full Text] [PDF]

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy Paul G. Richardson, Wanling Xie, Constantine Mitsiades, Asher A. Chanan-Khan, Sagar Lonial, Hani Hassoun, David E. Avigan, Anne Louise Oaklander, David J. Kuter, Patrick Y. Wen, Santosh Kesari, Hannah R. Briemberg, Robert L. Schlossman, Nikhil C. Munshi, L. Thompson Heffner, Deborah Doss, Dixie-Lee Esseltine, Edie Weller, Kenneth C. Anderson, and Anthony A. Amato JCO Jul 2009: 3518–3525. First published on Jun 15 2009; 10.1200/JCO.2008.18.3087. [Abstract] [Full Text] [PDF]

                                      PEDIATRIC ONCOLOGY

Cognitive Deficits and Predictors 3 Years After Diagnosis of a Pilocytic Astrocytoma in Childhood Femke K. Aarsen, Philippe F. Paquier, Willem-Frans Arts, Marie-Lise Van Veelen, Erna Michiels, Maarten Lequin, and Coriene E. Catsman-Berrevoets JCO Jul 2009: 3526–3532. First published on May 11 2009; 10.1200/JCO.2008.19.6303. [Abstract] [Full Text] [PDF]

Minimal Disseminated Disease in Childhood T-Cell Lymphoblastic Lymphoma: A Report From the Children's Oncology Group Elaine Coustan-Smith, John T. Sandlund, Sherrie L. Perkins, Helen Chen, Myron Chang, Minnie Abromowitch, and Dario Campana JCO Jul 2009: 3533–3539. First published on Jun 22 2009; 10.1200/JCO.2008.21.1318. [Abstract] [Full Text] [PDF]

                                      THORACIC ONCOLOGY

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics David R. Gandara, Tomoya Kawaguchi, John Crowley, James Moon, Kiyoyuki Furuse, Masaaki Kawahara, Satoshi Teramukai, Yuichiro Ohe, Kaoru Kubota, Stephen K. Williamson, Oliver Gautschi, Heinz Josef Lenz, Howard L. McLeod, Primo N. Lara, Jr, Charles Arthur Coltman, Jr, Masahiro Fukuoka, Nagahiro Saijo, Masanori Fukushima, and Philip C. Mack JCO Jul 2009: 3540–3546. First published on May 26 2009; 10.1200/JCO.2008.20.8793. [Abstract] [Full Text] [PDF]

                                      GYNECOLOGIC CANCER

Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial Remi A. Nout, Hein Putter, Ina M. Jürgenliemk-Schulz, Jan J. Jobsen, Ludy C.H.W. Lutgens, Elzbieta M. van der Steen-Banasik, Jan Willem M. Mens, Annerie Slot, Marika C. Stenfert Kroese, Bart N.F.M. van Bunningen, Vincent T.H.B.M. Smit, Hans W. Nijman, Philine P. van den Tol, and Carien L. Creutzberg JCO Jul 2009: 3547–3556. First published on Jun 22 2009; 10.1200/JCO.2008.20.2424. [Abstract] [Full Text] [PDF]

                                      PHASE I AND CLINICAL PHARMACOLOGY

Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors Roy S. Herbst, David Hong, Linnea Chap, Razelle Kurzrock, Edward Jackson, Jeffrey M. Silverman, Erik Rasmussen, Yu-Nien Sun, Don Zhong, Yuying C. Hwang, Jeffrey L. Evelhoch, Jonathan D. Oliner, NgocDiep Le, and Lee S. Rosen JCO Jul 2009: 3557–3565. First published on Jun 22 2009; 10.1200/JCO.2008.19.6683. [Abstract] [Full Text] [PDF]

                                      ERRATA

ERRATUM JCO Jul 2009: 3566. [Full Text] [PDF]

ERRATUM JCO Jul 2009: 3566. [Full Text] [PDF]

ERRATUM JCO Jul 2009: 3566. [Full Text] [PDF]

ERRATUM JCO Jul 2009: 3566–3567. [Full Text] [PDF]

ERRATUM JCO Jul 2009: 3567. [Full Text] [PDF]

                                      DIAGNOSIS IN ONCOLOGY

Extensive Soft-Tissue Metastases From Malignant Pleural Mesothelioma Tjeerd S. Aukema, Jaap J. Teunissen, Sjaak A. Burgers, Renée van Pel, and Wouter V. Vogel JCO Jul 2009: e24–e25. First published on Jun 8 2009; 10.1200/JCO.2008.21.0351. [Full Text] [PDF]

                                      CORRESPONDENCE

Natural History of CNS Relapse in Aggressive Non-Hodgkin's Lymphoma: What Have We Learned? Marc C. Chamberlain JCO Jul 2009: e26. First published on Jun 22 2009; 10.1200/JCO.2009.22.0608. [Full Text] [PDF]

Reply to M.C. Chamberlain Steven H. Bernstein, Joseph M. Unger, Michael LeBlanc, Jonathan Friedberg, Thomas P. Miller, and Richard I. Fisher JCO Jul 2009: e27–e28. First published on Jun 22 2009; 10.1200/JCO.2009.22.2166. [Full Text] [PDF]

Stopping Trials Early for Positive Results: The Need to Know How Much Carl D. Atkins JCO Jul 2009: e29. First published on Jun 22 2009; 10.1200/JCO.2009.23.8204. [Full Text] [PDF]

Reply to C.D. Atkins Edward L. Korn, Boris Freidlin, and Margaret Mooney JCO Jul 2009: e30. First published on Jun 22 2009; 10.1200/JCO.2009.23.8675. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.